Cardiac arrhythmias occur in millions of people worldwide and have been related with sudden cardiac death not only of heart failure patients but of healthy individuals as well. The existing pharmacological treatments focus mainly on the prevention of the symptoms rather than the pathogenetic mechanisms of arrhythmias. Additionally, drugs used to prevent arrythmias sometimes might have the opposite effect: they can cause arrhythmias.
In order to develop new specific drugs with greater and long-term effectiveness, it is required: i) in depth understanding of the molecular mechanisms of pathogenesis; ii) selection of the appropriate pharmaceutical compounds that might prevent the dysfunction of these mechanisms; iii) preclinical studies for the evaluation of the specific pharmaceutical compounds using an appropriate experimental model of cardiac arrhythmias.
Taking advantage of the new data that our research group had previously discovered regarding the molecular mechanisms that participate in physiological and pathological cardiac function, as well as the new, valuable for studying cardiac arrhythmias, genetically modified mouse model that we had created (junctin knockout, JKO), we performed a detailed characterization of two novel pharmaceutical compounds that were selected for their action on the molecular mechanisms of pathogenesis. Specifically, arrhythmias were induced in the JKO mice followed by administration of either of the two compounds. Extensive in vivo (intact mice) and in vitro (isolated cardiomyocytes) analysis demonstrated that one of the two substances significantly reduced arrhythmias at both levels (in vivo and in vitro). These findings suggest that the specific chemical compound could have a promising role in combating arrhythmias in the long run and merits further in depth analysis.
We use cookies to enhance your online experience, offer customized content according to your preferences, improve website’s performance and analyse the traffic.
By selecting “Accept all” you consent to the use of all cookies.
Cookies are small text files which are stored on your device when you visit our website. For further information on cookies, please read the website’s Terms of Use.
Categories of Cookies
Options
These cookies are absolutely necessary for the proper and secure operation of the website and they do not store information which identifies you. Therefore, they cannot be disabled and your consent for their use is not needed, in accordance with the current legislation.
These cookies collect information on how you use the website in order to improve your experience when visiting our website and collect statistical data, such as the website's traffic, the pages the users visit more often etc, by using Google Analytics tools.
These cookies are set and can only be read by the authorized provider of the website in order to personalize the content according to your preferences.
Targeting cookies store information regarding your personal interests and preferences. This type of cookies is not used to display advertisements or any other targeted commercial feature. Third parties may combine information you have provided to them or being collected by you on prior use of their services, for example when navigating to website’s pages embedded videos from our official channel in Youtube.
By selecting “Accept all” you consent to the use of all cookies.